125 related articles for article (PubMed ID: 11521195)
1. The role of the insulin receptor substrate-1 in the differentiation of rat hippocampal neuronal cells.
Morrione A; Navarro M; Romano G; Dews M; Reiss K; Valentinis B; Belletti B; Baserga R
Oncogene; 2001 Aug; 20(35):4842-52. PubMed ID: 11521195
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor I receptor signaling in differentiation of neuronal H19-7 cells.
Morrione A; Romano G; Navarro M; Reiss K; Valentinis B; Dews M; Eves E; Rosner MR; Baserga R
Cancer Res; 2000 Apr; 60(8):2263-72. PubMed ID: 10786694
[TBL] [Abstract][Full Text] [Related]
3. Essential role of insulin-like growth factor I receptor in insulin-induced fetal brown adipocyte differentiation.
Mur C; Arribas M; Benito M; Valverde AM
Endocrinology; 2003 Feb; 144(2):581-93. PubMed ID: 12538620
[TBL] [Abstract][Full Text] [Related]
4. Regulation of Id2 gene expression by the type 1 IGF receptor and the insulin receptor substrate-1.
Navarro M; Valentinis B; Belletti B; Romano G; Reiss K; Baserga R
Endocrinology; 2001 Dec; 142(12):5149-57. PubMed ID: 11713209
[TBL] [Abstract][Full Text] [Related]
5. Comparative signaling pathways of insulin-like growth factor-1 and brain-derived neurotrophic factor in hippocampal neurons and the role of the PI3 kinase pathway in cell survival.
Zheng WH; Quirion R
J Neurochem; 2004 May; 89(4):844-52. PubMed ID: 15140184
[TBL] [Abstract][Full Text] [Related]
6. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
[TBL] [Abstract][Full Text] [Related]
7. Insulin signaling leading to proliferation, survival, and membrane ruffling in C2C12 myoblasts.
Conejo R; Lorenzo M
J Cell Physiol; 2001 Apr; 187(1):96-108. PubMed ID: 11241354
[TBL] [Abstract][Full Text] [Related]
8. Retinoic acid-induced growth arrest of MCF-7 cells involves the selective regulation of the IRS-1/PI 3-kinase/AKT pathway.
del Rincón SV; Rousseau C; Samanta R; Miller WH
Oncogene; 2003 May; 22(22):3353-60. PubMed ID: 12776186
[TBL] [Abstract][Full Text] [Related]
9. Domains of the insulin-like growth factor I receptor required for the activation of extracellular signal-regulated kinases.
Dews M; Prisco M; Peruzzi F; Romano G; Morrione A; Baserga R
Endocrinology; 2000 Apr; 141(4):1289-300. PubMed ID: 10746631
[TBL] [Abstract][Full Text] [Related]
10. Activation of the insulin-like growth factor 1 signaling pathway by the antiapoptotic agents aurintricarboxylic acid and evans blue.
Beery R; Haimsohn M; Wertheim N; Hemi R; Nir U; Karasik A; Kanety H; Geier A
Endocrinology; 2001 Jul; 142(7):3098-107. PubMed ID: 11416032
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine phosphorylation-dependent and -independent role of Shc in the regulation of IGF-1-induced mitogenesis and glycogen synthesis.
Sasaoka T; Ishiki M; Wada T; Hori H; Hirai H; Haruta T; Ishihara H; Kobayashi M
Endocrinology; 2001 Dec; 142(12):5226-35. PubMed ID: 11713219
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor I induces preferential degradation of insulin receptor substrate-2 through the phosphatidylinositol 3-kinase pathway in human neuroblastoma cells.
Kim B; van Golen CM; Feldman EL
Endocrinology; 2005 Dec; 146(12):5350-7. PubMed ID: 16150916
[TBL] [Abstract][Full Text] [Related]
13. Insulin receptor substrate-1, p70S6K, and cell size in transformation and differentiation of hemopoietic cells.
Valentinis B; Navarro M; Zanocco-Marani T; Edmonds P; McCormick J; Morrione A; Sacchi A; Romano G; Reiss K; Baserga R
J Biol Chem; 2000 Aug; 275(33):25451-9. PubMed ID: 10846175
[TBL] [Abstract][Full Text] [Related]
14. Activation of the phosphatidylinositol-3' kinase pathway and DNA synthesis by a mutant insulin-like growth factor I receptor lacking the NPXY motif.
Kataoka K; Yu D; Miura M
J Endocrinol; 2004 Apr; 181(1):139-46. PubMed ID: 15072574
[TBL] [Abstract][Full Text] [Related]
15. Muscarinic-receptor-mediated inhibition of insulin-like growth factor-1 receptor-stimulated phosphoinositide 3-kinase signalling in 1321N1 astrocytoma cells.
Batty IH; Fleming IN; Downes CP
Biochem J; 2004 May; 379(Pt 3):641-51. PubMed ID: 14769130
[TBL] [Abstract][Full Text] [Related]
16. Deletion of the pleckstrin and phosphotyrosine binding domains of insulin receptor substrate-2 does not impair its ability to regulate cell proliferation in myeloid cells.
Sun H; Baserga R
Endocrinology; 2004 Nov; 145(11):5332-43. PubMed ID: 15297443
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine residues in the C-terminal domain of the insulin-like growth factor-I receptor mediate mitogenic and tumorigenic signals.
Esposito DL; Blakesley VA; Koval AP; Scrimgeour AG; LeRoith D
Endocrinology; 1997 Jul; 138(7):2979-88. PubMed ID: 9202243
[TBL] [Abstract][Full Text] [Related]
18. Progesterone receptor-B regulation of insulin-like growth factor-stimulated cell migration in breast cancer cells via insulin receptor substrate-2.
Ibrahim YH; Byron SA; Cui X; Lee AV; Yee D
Mol Cancer Res; 2008 Sep; 6(9):1491-8. PubMed ID: 18819936
[TBL] [Abstract][Full Text] [Related]
19. Rescue of TNFalpha-inhibited neuronal cells by IGF-1 involves Akt and c-Jun N-terminal kinases.
Kenchappa P; Yadav A; Singh G; Nandana S; Banerjee K
J Neurosci Res; 2004 May; 76(4):466-74. PubMed ID: 15114618
[TBL] [Abstract][Full Text] [Related]
20. Phosphoinositide 3-kinase-mediated reduction of insulin receptor substrate-1/2 protein expression via different mechanisms contributes to the insulin-induced desensitization of its signaling pathways in L6 muscle cells.
Pirola L; Bonnafous S; Johnston AM; Chaussade C; Portis F; Van Obberghen E
J Biol Chem; 2003 May; 278(18):15641-51. PubMed ID: 12594228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
